ICJIM

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

EndNote Style
Index
Letter to the Editor
Resetting the gut-brain axis in AN: the promise and pitfalls of FMT
Anorexia nervosa (AN) is a severe psychiatric disorder associated with high morbidity, mortality, and limited therapeutic options. Increasing evidence suggests that alterations in the gut microbiota and disruptions of the microbiota–gut–brain axis may contribute to the pathophysiology of AN by influencing appetite regulation, metabolism, and neuropsychiatric function. Fecal microbiota transplantation (FMT), which involves the transfer of gut microbiota from a healthy donor to a recipient, has emerged as a potential microbiome-based intervention aimed at restoring microbial balance and improving clinical outcomes. Preliminary studies have demonstrated improvements in gut microbial diversity, gastrointestinal function, and weight-related outcomes following FMT in individuals with AN. However, current evidence remains limited, with most data derived from animal models, case reports, and small pilot studies. Significant challenges include the lack of standardized treatment protocols, uncertain long-term safety, and ethical concerns regarding use in vulnerable populations. While FMT represents a promising avenue for future research, robust randomized controlled trials are required to establish its efficacy, safety, and role in clinical practice. At present, FMT should be regarded as a complementary investigational approach rather than a standard treatment for anorexia nervosa.


1. Flament MF, Henderson K, Buchholz A, et al. Weight status and DSM-5 diagnoses of eating disorders in adolescents from the community. J Am Acad Child Adolesc Psychiatry. 2015;54(5):403-411.e2. <a href="https://doi.org/10.1016/j.jaac.2015.01.020">doi:10.1016/j.jaac.2015.01.020</a>
2. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006;19(4):389-394. <a href="https://doi.org/10.1097/01.yco.0000228759.95237.78">doi:10.1097/01.yco.0000228759.95237.78</a>
3. Panah FM, Støving RK, Sjögren M, et al. Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial. Nat Commun. 2026;17(1):1747. <a href="https://doi.org/10.1038/s41467-026-68455-8">doi:10.1038/s41467-026-68455-8</a>
4. Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. <a href="https://doi.org/10.1152/physrev.00018.2018">doi:10.1152/physrev.00018.2018</a>
5. de Clercq NC, Frissen MN, Davids M, Groen AK, Nieuwdorp M. Weight gain after fecal microbiota transplantation in a patient with recurrent underweight following clinical recovery from anorexia nervosa. Psychother Psychosom. 2019;88(1):58-60. <a href="https://doi.org/10.1159/000495044">doi:10.1159/000495044</a>
6. Thelen AC, Korten NM, Blischke L, et al. Faecal microbiota transplantation in anorexia nervosa: a systematic review of methodologies, outcomes, and challenges with recommendations for future studies. Eur Eat Disord Rev. 2026. <a href="https://doi.org/10.1002/erv.70080">doi:10.1002/erv.70080</a>
Volume 4, Issue 3, 2026
Page : 74-75
_Footer